These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 21888239)
21. A case of fansidar-resistant Plasmodium falciparum from Tanzania. De Geus A; Meuwissen JH; van Rijn A Trop Geogr Med; 1982; 34(3):261-3. PubMed ID: 6758245 [No Abstract] [Full Text] [Related]
22. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. von Seidlein L; Milligan P; Pinder M; Bojang K; Anyalebechi C; Gosling R; Coleman R; Ude JI; Sadiq A; Duraisingh M; Warhurst D; Alloueche A; Targett G; McAdam K; Greenwood B; Walraven G; Olliaro P; Doherty T Lancet; 2000 Jan; 355(9201):352-7. PubMed ID: 10665554 [TBL] [Abstract][Full Text] [Related]
24. Pyrimethamine-sulfadoxine (Fansidar) resistance in a non-immune Kenyan--a case report. Nevill CG; Gardner A East Afr Med J; 1991 Feb; 68(2):149-51. PubMed ID: 2040235 [TBL] [Abstract][Full Text] [Related]
25. Comparative efficacy of combination fansidar-sulphate quinine and fansidar-chloroquine in mixed malaria infections of P. falciparum-P. vivax in children. Liando A; Rampengan TH Paediatr Indones; 1991; 31(3-4):99-103. PubMed ID: 1956694 [TBL] [Abstract][Full Text] [Related]
27. Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial. Tagbor H; Bruce J; Browne E; Randal A; Greenwood B; Chandramohan D Lancet; 2006 Oct; 368(9544):1349-56. PubMed ID: 17046467 [TBL] [Abstract][Full Text] [Related]
28. Chloroquine resistance in Plasmodium falciparum in KwaZulu, 1983-1988. Hansford CF S Afr Med J; 1989 Nov; 76(10):546-7. PubMed ID: 2686047 [TBL] [Abstract][Full Text] [Related]
29. Open randomized study of pyrimethamine-sulphadoxine vs. pyrimethamine-sulphadoxine plus probenecid for the treatment of uncomplicated Plasmodium falciparum malaria in children. Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Falade CO; Tambo E; Fateye BA; Happi TC; Oduola AM Trop Med Int Health; 2004 May; 9(5):606-14. PubMed ID: 15117306 [TBL] [Abstract][Full Text] [Related]
30. [Fansidar in the treatment of toxoplasmosis]. Michalová K; Ríhová E; Havlíková M Cesk Slov Oftalmol; 1996 Jul; 52(3):173-8. PubMed ID: 8768475 [TBL] [Abstract][Full Text] [Related]
31. Halofantrine versus quinine-Fansidar combination in the treatment of post-chloroquine falciparum parasitaemia. Hombhanje FW P N G Med J; 1998; 41(3-4):112-5. PubMed ID: 10934552 [TBL] [Abstract][Full Text] [Related]
32. Fansimef for prophylaxis of malaria: a double-blind randomized placebo controlled trial. Bunnag D; Malikul S; Chittamas S; Chindanond D; Harinasuta T; Fernex M; Mittelholzer ML; Kristiansen S; Sturchler D Southeast Asian J Trop Med Public Health; 1992 Dec; 23(4):777-82. PubMed ID: 1298089 [TBL] [Abstract][Full Text] [Related]
33. Adverse reactions to Fansidar and updated recommendations for its use in the prevention of malaria. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1985 Jan; 33(51-52):713-4. PubMed ID: 3917533 [No Abstract] [Full Text] [Related]
34. Pharmacokinetic interactions between chloroquine, sulfadoxine and pyrimethamine and their bioequivalence in a generic fixed-dose combination in healthy volunteers in Uganda. Obua C; Ntale M; Lundblad MS; Mahindi M; Gustafsson LL; Ogwal-Okeng JW; Anokbonggo WW; Hellgren U Afr Health Sci; 2006 Jun; 6(2):86-92. PubMed ID: 16916298 [TBL] [Abstract][Full Text] [Related]
35. The efficacy of sulphate quinine compared to fansidar in treating falciparum malaria in children 6 months-7 years old. Mogi G; Rampengan TH Paediatr Indones; 1991; 31(3-4):104-10. PubMed ID: 1956688 [TBL] [Abstract][Full Text] [Related]
36. Rapid increase in resistance of Plasmodium falciparum to chloroquine-Fansidar in Uganda and the potential of amodiaquine-Fansidar as a better alternative. Sendagire H; Kaddumukasa M; Ndagire D; Aguttu C; Nassejje M; Pettersson M; Swedberg G; Kironde F Acta Trop; 2005 Sep; 95(3):172-82. PubMed ID: 16018959 [TBL] [Abstract][Full Text] [Related]
37. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria. Ekue JM; Phiri DE; Sheth UK; Mukunyandela M Bull World Health Organ; 1987; 65(3):369-73. PubMed ID: 3311440 [TBL] [Abstract][Full Text] [Related]
38. The in vitro effects of sulfadoxine/pyrimethamine and artemether/lumefantrine on the viscoelasticity of erythrocyte membrane of healthy females. Richards PD; Richards AA; McKoy MG; Pepple DJ Clin Hemorheol Microcirc; 2014; 58(4):507-14. PubMed ID: 24169096 [TBL] [Abstract][Full Text] [Related]
39. Induction of sister chromatid exchanges by pyrimethamine in human lymphocyte cultures. Egeli U Teratog Carcinog Mutagen; 1998; 18(4):163-9. PubMed ID: 9804272 [TBL] [Abstract][Full Text] [Related]
40. Falciparum malaria resistant to Fansidar (sulphadoxine-pyrimethamine) occurring in three children of the same family. Ponnampalam JT Singapore Med J; 1982 Feb; 23(1):37-8. PubMed ID: 7051329 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]